Completed NA INTERVENTIONAL NCT03337347

Clinical Significance of Detecting CEA and CK20 mRNA-positive Cells in Colorectal Cancer Patients

Sponsor: The Institute of Molecular and Translational Medicine, Czech Republic

Conditions Circulating Tumor Cell Colorectal Cancer

Updated 6 times since 2017 Last updated: Oct 11, 2019 Started: Jan 1, 2004 Primary completion: Feb 28, 2007 Completion: Oct 23, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Circulating Tumor Cell and Colorectal Cancer and is currently completed. The Institute of Molecular and Translational Medicine, Czech Republic leads this study, which shows 6 recorded versions since 2004 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Nov 2019 — Jan 2021 [monthly]

Completed NA
Jun 2018 — Nov 2019 [monthly]

Completed NA

▶ Show 1 earlier version

Dec 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Jan 2004

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

The Institute of Molecular and Translational Medicine, Czech Republic

Data source: The Institute of Molecular and Translational Medicine, Czech Republic

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Olomouc, Czechia